"It would be of the utmost importance if management would clarify this rumour that has been confirmed by some in EMEA, some around GTCB, some in the field , some of people working at Pharming."
First of all, if GTCB has indeed done so, they were right to do so, because it is clear that the guiding document provided by the EMEA in 2000-2001 was apparently not endorsed by the EMEA committee dealing with GTCB's application for approval at a later stage. So the blame is on the EMEA.
You wrote me that this has been told by someone working at Pharming. Could you tell me who are the ones at the EMEA, around GTCB and in the field who have confirmed this to you?